7.08
+0.01(+0.14%)
Currency In USD
Address
9237 East Via de Ventura Boulevard
Scottsdale, AZ 85258
United States of America
Phone
480 434 6670
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
41
First IPO Date
November 12, 2021
| Name | Title | Pay | Year Born |
| Mr. Claude Maraoui | Founder, President, Chief Executive Officer & Director | 975,434 | 1967 |
| Dr. Lindsay Allan Rosenwald | Executive Chairman | 50,000 | 1955 |
| Mr. Joseph M. Benesch | Chief Financial Officer & Corporate Controller | 434,088 | 1967 |
| Mr. Louis Donati | Director of Market Access | 0 | N/A |
| Jaclyn Jaffe | Senior Director of Corporate Operations | 0 | N/A |
| Mr. Ramsey Alloush | Chief Operating Officer, General Counsel & Company Secretary | 0 | 1986 |
| Mr. Robert Nevin | Chief Commercial Officer | 0 | 1969 |
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.